Log In
Print this Print this


Also known as: AAV1-FS

  Manage Alerts
Collapse Summary General Information
Company Milo Biotechnology LLC
DescriptionAdeno-associated virus (AAV) vector used to deliver follistatin
Molecular Target Myostatin (MSTN) (GDF8)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector
Latest Stage of DevelopmentPhase I/II
Standard IndicationMuscular dystrophy
Indication DetailsTreat Becker and Duchenne muscular dystrophy (DMD); Treat Becker muscular dystrophy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today